A web-blog (formerly known as Stu's Views and MS News), now published by MS Views and News, a patient advocacy organization. The information on this blog helps to Empower those affected by Multiple Sclerosis globally, with education, information, news and community resources.
~~ Scroll left side of this blog for needed resources. Also, use our 'search by topic' tool, to find specific information.
Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.
Wednesday, September 25, 2013
New imaging test for multiple sclerosis developed at Case could help speed up new treatments & Discoveries
CLEVELAND, Ohio-- Multiple sclerosis, an immune-related disease of the brain and spinal cord that causes muscle spasms, numbness and difficulty walking, has no cure. Several treatments can stabilize the disease early in its course or slow it down once it has advanced, but many of them have serious side effects.
One of the impediments to advancing research on new treatments for MS is that there is no imaging test that can track or show the exact state of damage to the myelin, which is the fatty protective insulation to the nerves that is broken down during the disease.
Now, researchers at Case Western Reserve University think they have found a way to do just that, using positron emission tomography, or PET imaging and a molecular marker called MeDAS. By injecting MeDAS into the spinal cords of mice and rats that have an animal model of the disease, they were able to show, and quantify, the damage done to the animals’ myelin.
“This is a highly desired technique in the medical community,” said Yanming Wang, senior author of the paper describing their findings published Monday in the journal Annals of Neurology, and associate professor of radiology at Case. “[Drug companies] have myelin-repairing drugs in development but no way to measure their effectiveness in a quantitative way. This imaging technique could allow them to do that.”
Wang said the technique may also be of use in other diseases that involve nervous system damage, such as Alzheimer’s disease, spinal cord injury and stroke.
Wang’s group, at Case’s Center for Imaging Research, has been working on the problem for a decade, he said. It’s been difficult to find a molecule that could penetrate into the brain and attach itself to the myelin in the spinal cord and nowhere else in the body. MeDAS was able to do that.
The traditional imaging test for diagnosing MS is magnetic resonance imaging, or MRI. This technique can show inflammation and is pretty reliable at helping diagnose the disease in its early stages, but cannot accurately track the disease’s progression. PET imaging uses a different method to take pictures of the brain and spinal cord that reveals how well these tissues are functioning at any given time.
PET can, for example, tell doctors if a patient’s nerves are still working in the spinal cord or if there has been additional loss of myelin over time, Wang said. It is therefore potentially much more valuable as a tool to track the progress of the disease or to see if a treatment is working, he said.